Tigecycline-induced pancreatitis

Journal of Clinical Gastroenterology

Volumn 43, Issue 1, 2009, Pages 93-

  Lipshitz, Jay ^a   Kruh, Jonathan ^a   Cheung, Philip ^b   Cassagnol, Manouchkathe ^a,c  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TIGECYCLINE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LABORATORY TEST; LETTER; PANCREATITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ABDOMINAL PAIN; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MIDDLE AGED; MINOCYCLINE; NAUSEA; PANCREATITIS; VOMITING;

EID: 67651165165     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318164939c     Document Type: Letter

References (4)

1. Biedenbach DJ, Beach ML, Jones RN. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant Gram positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases. Diagn Microbiol Infect Dis. 2001;40:173-177.
2. Wyeth Pharmaceuticals Inc. Tygacil® (Tigecycline) for Injection. Prescribing Information. Philedelphia, PA; 2005.
3. Nicolau DP, Mengedoht DE, Kline JJ. Tetracycline-induced pancreatitis. Am J Gastroenterol. 1991;86:1669-1671.
4. Naranjo CA, Busto U, Sellers EM, et al. A method of estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245. (Pubitemid 11140804)